These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 4952077)

  • 1. Experimental hepatitis induced by D-galactosamine.
    Keppler D; Lesch R; Reutter W; Decker K
    Exp Mol Pathol; 1968 Oct; 9(2):279-90. PubMed ID: 4952077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Animal disease models--injury, death and various changes of liver cells].
    Taoka Y
    Nihon Rinsho; 1985 Jun; 43(6):1239-50. PubMed ID: 3900478
    [No Abstract]   [Full Text] [Related]  

  • 3. 45Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo.
    Schiessel C; Forsthove C; Keppler D
    Hepatology; 1984; 4(5):855-61. PubMed ID: 6207090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphological characteristics of D-galactosamine hepatitis].
    Popov A; Klouchek-Popova E; Stoilova M
    Eksp Med Morfol; 1983; 22(2):74-80. PubMed ID: 6667658
    [No Abstract]   [Full Text] [Related]  

  • 5. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reaction of the hepatic tissue of various laboratory animals to single administration of thioacetamide].
    Förster M
    Beitr Pathol Anat; 1969; 139(4):421-38. PubMed ID: 5364615
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of activated polymorphonuclear leukocytes in galactosamine-induced hepatic injury in rats.
    Hino Y; Kumashiro R; Tanaka M; Shimada M; Harada M; Yoshitake M; Sata M; Tanikawa K
    Gastroenterol Jpn; 1991 Aug; 26(4):545. PubMed ID: 1655555
    [No Abstract]   [Full Text] [Related]  

  • 8. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of hepatotoxicity by macrophages in the liver.
    Shiratori Y; Kawase T; Shiina S; Okano K; Sugimoto T; Teraoka H; Matano S; Matsumoto K; Kamii K
    Hepatology; 1988; 8(4):815-21. PubMed ID: 2839405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity of D-galactosamine in the isolated perfused rat liver.
    Rasenack J; Koch HK; Nowack J; Lesch R; Decker K
    Exp Mol Pathol; 1980 Jun; 32(3):264-75. PubMed ID: 7379980
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats.
    Lesch R; Reutter W; Keppler D; Decker K
    Exp Mol Pathol; 1970 Feb; 12(1):58-69. PubMed ID: 5418074
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats].
    Adzharov D; Donchev N; Kerimova M; Naĭdenova E; Borov B
    Biull Eksp Biol Med; 1989 Jan; 107(1):33-6. PubMed ID: 2914170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on severe hepatic damage induced by galactosamine.
    Ozeki T; Kan M; Yamagata S; Taoka Y
    Gastroenterol Jpn; 1982 Apr; 17(2):87-92. PubMed ID: 6179814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of hepatotoxicity by ethanol in galactosamine-induced hepatitis in rats: role of propylthiouracil protection.
    Nadkarni GD; Naik SB; Talavdekar RV; Soman CS; Talwalkar GV; Ganatra RD
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):90-4. PubMed ID: 6846026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of galactosamine on hepatic carbohydrate metabolism: protective role of fructose 1,6-bisphosphate.
    De Oliveira JR; Rosa JL; Ambrosio S; Bartrons R
    Hepatology; 1992 Jun; 15(6):1147-53. PubMed ID: 1317340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-galactosamine-induced liver injury in immunosuppressed mice.
    Schaff Z; Lapis K; Szendröi M
    Acta Morphol Hung; 1984; 32(1):67-72. PubMed ID: 6087623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism and excretion of [14C]imipramine in an experimental hepatitis.
    Hackett AM; Shaw IC; Griffiths LA
    Xenobiotica; 1984 Jun; 14(6):491-9. PubMed ID: 6475108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of extracellular matrix in acute galactosamine hepatitis in rats.
    Jonker AM; Dijkhuis FW; Boes A; Hardonk MJ; Grond J
    Hepatology; 1992 Mar; 15(3):423-31. PubMed ID: 1371983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic aggregates in D-galactosamine induced liver injury.
    Tompa A; Lapis K; Schaff Z; Mészáros K; Mandl J; Garzó T; Antoni F
    Acta Morphol Acad Sci Hung; 1977; 25(4):239-57. PubMed ID: 617770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.